Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MM

Clinical trial NCT03706547 · UNKNOWN

Trial details

NCT number: NCT03706547
Sponsor: Peng Liu
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Multiple Myeloma Progression

Start date: 2018-10-30
Primary completion: 2020-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.